Literature DB >> 22739804

P2Y12 inhibitors in acute coronary syndromes: how do we choose the best drug for our patients?

Steen D Kristensen, Erik L Grove, Anne-Mette Hvas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22739804     DOI： 10.1160/TH12-06-0430

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN： 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  2 in total

Review 1.  [Antiplatelet therapy after acute coronary syndrome. Therapeutic strategies and treatment duration].

Authors:  C B Olivier; P Diehl; C Bode; M Moser
Journal:  Herz       Date:  2014-11       Impact factor: 1.443

Review 2.  Receptors, endocytosis, and trafficking: the biological basis of targeted delivery of antisense and siRNA oligonucleotides.

Authors:  R L Juliano; K Carver; C Cao; X Ming
Journal:  J Drug Target       Date:  2012-11-19       Impact factor: 5.121
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.